News from the FDA/CDC

Mental health visits account for 19% of ED costs


 

Emergency department visits for mental and substance use disorders (MUSDs) cost $14.6 billion in 2017, representing 19% of the total for all ED visits that year, according to the Agency for Healthcare Quality and Research.

ED visit costs for mental and substance use disorders, 2017

In terms of the total number of visits for MUSDs, 23.1 million, the proportion was slightly lower: 16% of all ED visits for the year, Zeynal Karaca, PhD, a senior economist with AHRQ, and Brian J. Moore, PhD, a senior research leader at IBM Watson Health, said in a recent statistical brief.

Put those figures together and the average visit for an MUSD diagnosis cost $630 and that is 19% higher than the average of $530 for all 145 million ED visits, they reported based on data from the Nationwide Emergency Department Sample.

The most costly MUSD diagnosis in 2017 was anxiety and fear-related disorders, with a total of $5.6 billion for ED visits, followed by depressive disorders at $4.7 billion and alcohol-related disorders at $2.7 billion. Some ED visits may involve more than one MUSD diagnosis, so the sum of all the individual diagnoses does not agree with the total for the entire MUSD category, the researchers noted.

On a per-visit basis, mental and substance use disorders in remission, at $690, was the most expensive of the 20 most costly MUSD diagnoses in 2017. [It was not included in the graph because it was 13th.] Other disorders with high per-visit costs were alcohol-related ($670), cannabis-related ($660), and depressive and stimulant-related (both with $650), Dr. Karaca and Dr. Moore said.

Patients with MUSDs who were routinely discharged after an ED visit in 2017 represented a much lower share of the total MUSD cost (68.0%), compared with the overall group of ED visitors (81.4%), but MUSD visits resulting in an inpatient admission made up a larger proportion of costs (19.0%), compared with all visits (9.5%), they said.

Costs between MUSD visits and all ED visits also differed by patient age. Visits by patients aged 0-9 years represented only 0.7% of MUSD-related ED costs but 5.6% of the overall cost, but the respective figures for those aged 45-64 were 36.2% for MUSD costs and 28.5% for the total ED cost, they reported.

SOURCE: Karaca Z and Moore BJ. HCUP Statistical Brief #257. May 12, 2020.

Recommended Reading

COVID-19 effect: Prescription fills mostly down for leading drugs
MDedge Internal Medicine
COVID-19: An opportunity to rehumanize psychiatry
MDedge Internal Medicine
COVID-19: New group stands up for health professionals facing retaliation
MDedge Internal Medicine
Today’s top news highlights: Addressing racism in maternity care, group forms to protect health professionals from retaliation
MDedge Internal Medicine
Cardiology societies unite to denounce racist violence
MDedge Internal Medicine
Doctors’ top telehealth coding questions answered
MDedge Internal Medicine
Today’s Top News Highlights: Your coding questions answered, biologics and melanoma, and more
MDedge Internal Medicine
Rapid changes to health system spurred by COVID might be here to stay
MDedge Internal Medicine
Daily Recap: How to stay afloat financially during COVID-19, more bad news on e-cigs
MDedge Internal Medicine
Money worries during COVID-19? Six tips to keep your finances afloat
MDedge Internal Medicine